PLASMA GASTRIN, DAYTIME INTRAGASTRIC PH, AND NOCTURNAL ACID OUTPUT BEFORE AND AT 1 AND 7 MONTHS AFTER ERADICATION OF HELICOBACTER-PYLORI IN DUODENAL-ULCER SUBJECTS

被引:151
作者
MCCOLL, KEL
FULLARTON, GM
CHITTAJALU, R
ELNUJUMI, AM
MACDONALD, AMI
DAHILL, SW
HILDITCH, TE
机构
[1] UNIV GLASGOW,WESTERN INFIRM,DEPT MED,GLASGOW G11 6NT,SCOTLAND
[2] UNIV GLASGOW,WESTERN INFIRM,DEPT SURG,GLASGOW G11 6NT,SCOTLAND
[3] UNIV GLASGOW,WESTERN INFIRM,DEPT PATHOL,GLASGOW G11 6NT,SCOTLAND
[4] DEPT CLIN PHYS & BIOENGN,GLASGOW,SCOTLAND
关键词
ACID SECRETION; DUODENAL ULCER; GASTRIN; HELICOBACTER-PYLORI; INTRAGASTRIC PH;
D O I
10.3109/00365529109025052
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nine patients with Helicobacter pylori-related antral gastritis and history of duodenal ulceration were studied before and at 1 and 7 months after eradication of the infection by a 4-week course of tripotassium dicitrato bismuthate, metronidazole, and amoxycillin. The median basal gastrin concentration before eradication was 30 ng/l (range, 20-60) and fell to 20 ng/l (5-20) at 1 month (p < 0.02) and 15 ng/l (5-20) at 7 months (p < 0.01) after eradication. The integrated gastrin response to a peptide meal was 3650 ng/l.min (range, 1875-6025) before treatment compared with 1800 ng/l.min (range, 1200-3075) at 1 month (p < 0.01) and 1312 ng/l.min (875-2625) at 7 months (p < 0.03). Daytime intragastric pH (0900-2100 h) was similar before treatment (median, 1.4; range, 1.1-2.1) and at 1 month (1.4;1.1-2.3) and 7 months (1.4; 1-2.2) after eradication. In five of the patients nighttime acid output (2300-0900 h) was also studied and was similar before (median, 86 mmol/10 h; range, 52-114) and at 1 month (76 mmol/10 h; 50-143) and 7 months (94 mmol/10 h; 63-106) after eradication. In conclusion, eradication of H. pylori is accompanied by a sustained fall in serum gastrin concentrations but is not accompanied by an early or late reduction of daytime intragastric acidity or nighttime acid output.
引用
收藏
页码:339 / 346
页数:8
相关论文
共 19 条
[1]  
ARDILL JES, 1973, THESIS QUEENS U BELF
[2]  
BELL GD, 1987, LANCET, V1, P1367
[3]  
Bumm R, 1987, Aliment Pharmacol Ther, V1 Suppl 1, p518S
[4]  
CREAN GP, 1969, GASTROENTEROLOGY, V57, P147
[5]  
DEFIZE J, 1988, GUT, V9, pA1435
[6]  
GRAHAM D, 1988, AM J GASTROENTEROL, V83, P976
[7]   CAMPYLOBACTER-PYLORI AND PEPTIC-ULCER DISEASE [J].
GRAHAM, DY .
GASTROENTEROLOGY, 1989, 96 (02) :615-625
[8]   ANTRAL HELICOBACTER-PYLORI, HYPERGASTRINEMIA, AND DUODENAL-ULCERS - EFFECT OF ERADICATING THE ORGANISM [J].
LEVI, S ;
BEARDSHALL, K ;
SWIFT, I ;
FOULKES, W ;
PLAYFORD, R ;
GHOSH, P ;
CALAM, J .
BRITISH MEDICAL JOURNAL, 1989, 299 (6714) :1504-1505
[9]  
LEVI S, 1989, LANCET, V1, P1167
[10]  
MARSHALL BJ, 1987, AM J GASTROENTEROL, V82, P200